Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jonathan Popler

Pediatrics Atlanta, GA Medical Doctor

NPI 1154542389 CMS profile 98173

859 Mount Vernon Hwy Ne Ste 300, Atlanta, GA 30328

Open in the dashboard

General payments

$16,651

46 records reported · program years 2019–2025

Research payments

$10,763

Paid to them · 5 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jonathan Popler of Atlanta, GA is reported in the CMS Open Payments database as having received $16,651 across 46 general payments and $10,763 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $84 4
2025 Research $7,388 4
2024 General $147 3
2024 Research $3,375 1
2023 General $4,772 4
2022 General $8,490 9
2021 General $2,659 5
2020 General $312 11
2019 General $187 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jonathan Popler
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Jonathan Popler were reported at $84. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Jonathan Popler Pediatrics median Middle half National median
2019 $187 $86 $31–$183 $163
2020 $312 $49 $22–$110 $114
2021 $2,659 $68 $27–$158 $132
2022 $8,490 $77 $30–$173 $149
2023 $4,772 $88 $33–$190 $160
2024 $147 $94 $34–$206 $164
2025 $84 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boehringer Ingelheim Pharmaceuticals, Inc. $8,315 11 payments
  2. Boehringer Ingelheim International GmbH $4,988 4 payments
  3. Boehringer Ingelheim Italia S.p.A. $2,588 1 payment
  4. AstraZeneca Pharmaceuticals LP $461 17 payments
  5. NS Pharma, Inc. $110 1 payment
  6. GlaxoSmithKline, LLC. $87 6 payments
  7. Advanced Respiratory, Inc $23 1 payment
  8. Vapotherm Inc $22 1 payment
  9. Covis Pharma B.V. $21 1 payment
  10. Sobi, Inc $17 1 payment
  11. Other $21 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $14,785 6 payments
  2. Food and Beverage $1,025 37 payments
  3. Travel and Lodging $841 3 payments
Products named General payments · program years 2019–2025
  1. OFEV Respiratory $13,081 10 payments
  2. OFEV Respiratory $2,588 1 payment
  3. FASENRA Respiratory $137 7 payments
  4. VILTEPSO $110 1 payment
  5. FASENRA Respiratory $108 5 payments
  6. NUCALA $75 5 payments
  7. SPIRIVA RESPIMAT $62 3 payments
  8. The Vest System Model 105 Home Care $23 1 payment
  9. VAPOTHERM $22 1 payment
  10. ALVESCO $21 1 payment
  11. Other $55 4 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Boehringer Ingelheim International GmbH $10,763 5 payments

Records

51 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record